All News

Another agent – Cinvanti (aprepitant) injectable emulsion – was approved by the Food and Drug Administration (FDA) to treat chemotherapy-induced nausea/vomiting (CINV).

A new drug was approved for patients with cutaneous T-cell lymphoma (CTCL).

Shock is a typical feeling that comes with a cancer diagnosis. How do you overcome it?

Don’t people with cancer, as consumers of health care, deserve an equally personalized approach to cancer treatment as we have come to expect in other areas of our daily life?

After being a cancer caregiver, it's important to step back and gain perspective.

Prevyis (letermovir) was granted approval by the Food and Drug Administration (FDA) to prevent cytomegalovirus (CMV) infection in adult CMV-seropositive patients treated with an allogeneic hematopoietic stem cell transplant (HSCT). The result is based on a significant reduction in CMV infection rates in a phase 3 study.

Liver cancer diagnoses have increased in the past 25 years, but researchers are hopeful that they will start to drop.

A cancer survivor talks about the importance of hope, inspired by her reading of Viktor Frankl's Man's Search for Meaning, which analyzes the psychological strength of Holocaust survivors.

New treatment regimens may be hitting the scene of myeloma treatment.

One of the hardest side effects from cancer is the fatigue. This survivor explains why it is so important for cancer survivors to not overdo.

As a caregiver, it is crucial that you learn to ask for help.

In cancer, communication is critical.

National non-profit begins a new chapter revealing new name, logo, and inclusive mission.

Alecensa (alectinib) was granted approval by the Food and Drug Administration (FDA) to treat patients with ALK-positive metastatic non–small cell lung cancer (NSCLC), according to Genentech (Roche), the manufacturer of the second-generation ALK inhibitor.

Zelboraf (vemurafenib) became the first approved drug to treat Erdheim-Chester disease (ECD).

Alfred L. Garfall lends insight as to what is new for myeloma treatment.

Lymphedema is not an uncommon secondary effect of cancer treatment. With no cure available, an effective long-term treatment effort is necessary for maximizing a cancer survivor's quality of life.